UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

European journal of clinical pharmacology, 2021-12, Vol.77 (12), p.1815-1823

2021

Volltextzugriff (PDF)

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Clinical pharmacology and therapeutics, 2018-07, Vol.104 (1), p.111-119

2018

Volltextzugriff (PDF)

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs

Journal of veterinary pharmacology and therapeutics, 2018-02, Vol.41 (1), p.60-67

2018

Volltextzugriff (PDF)

Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects

British journal of clinical pharmacology, 2014-08, Vol.78 (2), p.320-328

2014

Volltextzugriff (PDF)

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low-Dose Aspirin

Journal of veterinary internal medicine, 2013-01, Vol.27 (1), p.141-149

2013

Volltextzugriff (PDF)

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Journal of thrombosis and haemostasis, 2006-06, Vol.4 (6), p.1271-1278

2006

Volltextzugriff (PDF)

Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels

Clinica chimica acta, 2014-02, Vol.429, p.76-78

2014

Volltextzugriff (PDF)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease

Drug design, development and therapy, 2018-01, Vol.12, p.1353-1362

2018

Volltextzugriff (PDF)

Human pharmacology of naproxen sodium

The Journal of pharmacology and experimental therapeutics, 2007-08, Vol.322 (2), p.453

2007

Volltextzugriff (PDF)

Differential Impact of Inflammation on Six Laboratory Assays Measuring Residual Arachidonic Acid-Inducible Platelet Reactivity During Dual Antiplatelet Therapy

Journal of Atherosclerosis and Thrombosis, 2013, Vol.20(7), pp.630-645

2013

Volltextzugriff (PDF)

Aspirin Resistance in Different Doses by Bleeding Time and Urinary 11-dehydro-thromboxane B2

Indian journal of physiology and pharmacology, 2016-01, Vol.60 (1), p.30-37

2016

Volltextzugriff (PDF)

Platelet Response to Aspirin in Chinese Stroke Patients is Independent of Genetic Polymorphisms of COX-1 C50T and COX-2 G765C

Journal of Atherosclerosis and Thrombosis, 2013, Vol.20(1), pp.65-72

2013

Volltextzugriff (PDF)

Platelet Cyclooxygenase Expression in Normal Dogs

Journal of veterinary internal medicine, 2011-09, Vol.25 (5), p.1106-1112

2011

Volltextzugriff (PDF)

Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs

American journal of veterinary research, 2011-08, Vol.72 (8), p.1038-1045

2011

Volltextzugriff (PDF)

Aspirin resistance may be associated with adverse pregnancy outcomes

Neuro-endocrinology letters, 2011, Vol.32 (3), p.334-339

2011

Volltextzugriff (PDF)

Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk"

Circulation (New York, N.Y.), 2009-06, Vol.119 (24), p.e594; author reply e595-e596

Cattaneo, Marco

2009

Volltextzugriff (PDF)

The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients

Genetic testing and molecular biomarkers, 2011-07, Vol.15 (7-8), p.513

2011

Volltextzugriff (PDF)

Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)

Thrombosis and haemostasis, 2009-08, Vol.102 (2), p.404

2009

Volltextzugriff (PDF)

Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease

Journal of thrombosis and thrombolysis, 2010, Vol.29 (1), p.108-113

2010

Volltextzugriff (PDF)

The purification step is not crucial in EIA measurements of thromboxane B2 and 11-dehydrothromboxane B2 in human plasma

Clinical laboratory (Heidelberg), 2012, Vol.58 (1-2), p.177

2012

Volltextzugriff (PDF)

Platelet Aggregation and Recruitment with Aspirin-Clopidogrel Therapy

Cerebrovascular diseases (Basel, Switzerland), 2008-05, Vol.25 (5), p.392-400

2008

Volltextzugriff (PDF)

A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane

Anesthesia and analgesia, 2013-02, Vol.116 (2), p.282-286

2013

Volltextzugriff (PDF)

Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events

Journal of postgraduate medicine, 2009-10, Vol.55 (4), p.252

2009

Volltextzugriff (PDF)

Can Platelet Function Tests Predict the Clinical Efficacy of Aspirin?

Seminars in thrombosis and hemostasis, 2005, Vol.31 (4), p.404-410

2005

Volltextzugriff (PDF)

AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect

Molecular diagnosis & therapy, 2008, Vol.12 (1), p.51-54

2008

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect_期刊（NSTL购买）

Zeitschrift / SerieThrombosis Research

ThemaBiological And Medical Sciences

ThemaAspirin - Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(67)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(51)
Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Male
(39)
Female
(35)
Thromboxane B2 - Analogs & Derivatives
(35)
Thromboxane B2 - Urine
(33)
Blood Platelets - Drug Effects
(28)
Platelet Aggregation Inhibitors - Pharmacology
(26)
Animals
(21)
Middle Aged
(21)
Platelet Aggregation - Drug Effects
(21)
Adult
(20)
Aspirin
(18)
Blood Platelets - Metabolism
(17)
Thromboxane B2 - Blood
(17)
Cyclooxygenase Inhibitors - Pharmacology
(16)
Pharmacology & Pharmacy
(16)
Aged
(15)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs

Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low-Dose Aspirin

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease

Human pharmacology of naproxen sodium

Differential Impact of Inflammation on Six Laboratory Assays Measuring Residual Arachidonic Acid-Inducible Platelet Reactivity During Dual Antiplatelet Therapy

Aspirin Resistance in Different Doses by Bleeding Time and Urinary 11-dehydro-thromboxane B2

Platelet Response to Aspirin in Chinese Stroke Patients is Independent of Genetic Polymorphisms of COX-1 C50T and COX-2 G765C

Platelet Cyclooxygenase Expression in Normal Dogs

Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs

Aspirin resistance may be associated with adverse pregnancy outcomes

Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk"

The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients

Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)

Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease

The purification step is not crucial in EIA measurements of thromboxane B2 and 11-dehydrothromboxane B2 in human plasma

Platelet Aggregation and Recruitment with Aspirin-Clopidogrel Therapy

A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane

Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events

Can Platelet Function Tests Predict the Clinical Efficacy of Aspirin?

AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect

Aktive Filter

Suchergebnisse filtern